<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04835259</url>
  </required_header>
  <id_info>
    <org_study_id>Soh-Med-21-01-10</org_study_id>
    <nct_id>NCT04835259</nct_id>
  </id_info>
  <brief_title>Efficacy of Topical Antioxidants in Tretment of Photoaging</brief_title>
  <official_title>Efficacy of a Combination of Topical Antioxidants in Tretment of Photoaged Skin:A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sohag University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sohag University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomized controlled trial study aims at investigating the efficacy and safety of&#xD;
      topical antioxidants in treatment of a cohort of non-elderly volunteers with photoaged skin.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      •Sample size calculation: The sample size was assessed prospectively using Openepi version&#xD;
      3.01 to provide a 80% power to detect a 40-50% difference before and after treatment using&#xD;
      either topical antioxidants or retinoids with a significance level of 0.05 (based on the&#xD;
      results of a previous clinical trial). Assuming 10% dropout, 30 patients will be recruited in&#xD;
      each treatment group.&#xD;
&#xD;
      •Statistical analysis: Data will be collected and recorded on excel data sheet. Data will be&#xD;
      tested for normality. Quantitative data will be represented as mean and standard deviation,&#xD;
      or median and interquartile range. Qualitative data will be presented as number and&#xD;
      percentage. The relevant statistical method will be used for comparison. P value will be&#xD;
      considered statistically significant if it is less than 0.05&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 2021</start_date>
  <completion_date type="Anticipated">June 2022</completion_date>
  <primary_completion_date type="Anticipated">April 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change in Dermoscopy photoaging scale</measure>
    <time_frame>assesed every month for 6 months</time_frame>
    <description>Dermoscopy photoaging scale (DPAS) is a reliable and valid diagnostic tool that can evaluate photoaged skin quantitatively by the help of objective criteria. It can be used to evaluate the effect of preventive and therapeutic applications for skin aging.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Photoaging</condition>
  <arm_group>
    <arm_group_label>Group 1(treatment group)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Topical application of a cream of a combination of antioxidants once daily at night for 6 months Name: Selenium ACE cream (Interpharma UK company, Egypt)&#xD;
Ingredients:&#xD;
Selenium (Selenium amino acid chelate) 0.5% Vitamin C (Sodium ascorbyl phosphate - stay C) %1 Vitamin E (Tocopheryl acetate) % 0.5 Vitamin A (Retinyl palmitate) %1 Emulsifiers ( Ceteareth 20 , Glycerol monostearate , Cetyl alcohol) Emollient(Caprylic capric triglycerides)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2 (positive control)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Topical application of a retinoid (tretinoin 0.05%) cream once daily at night for 6 months (Acretin 0.05% cream Jamjoom pharmaceuticals, Egypt)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 3 (Negative control)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Topical application of a panthenol cream once daily at night for 6 months (panthenol 2% cream, El Nile company, Egypt)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Selenium Amino Acid Chelate (Selenium ACE cream)</intervention_name>
    <description>application of a topical agent over the whole face for 6 months</description>
    <arm_group_label>Group 1(treatment group)</arm_group_label>
    <arm_group_label>Group 2 (positive control)</arm_group_label>
    <arm_group_label>Group 3 (Negative control)</arm_group_label>
    <other_name>topical retinoid (Acretin 0.05% cream)</other_name>
    <other_name>topical panthenol (Panthenol cream)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult volunteers &lt; 50 years old&#xD;
&#xD;
          -  Clinical and dermoscopic features of photoaging.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Genodermatoses associated with photosensitivity.&#xD;
&#xD;
          -  Treatment by medications affecting skin aging (eg, topical and systemic retinoids) in&#xD;
             the last 6 months prior to enrollment.&#xD;
&#xD;
          -  Any recent cosmetic procedures.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>esraa ismail</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sohag University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>esraa ismail</last_name>
    <phone>00201000509636</phone>
    <email>esraasalah123@yahoo.com</email>
  </overall_contact>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>January 19, 2021</study_first_submitted>
  <study_first_submitted_qc>April 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 8, 2021</study_first_posted>
  <last_update_submitted>April 18, 2021</last_update_submitted>
  <last_update_submitted_qc>April 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sohag University</investigator_affiliation>
    <investigator_full_name>esraa ismail</investigator_full_name>
    <investigator_title>assistant lecturer</investigator_title>
  </responsible_party>
  <keyword>topical antioxidants</keyword>
  <keyword>photoaged skin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Skin Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Selenium</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

